Zim Laboratories is currently trading at Rs. 155.00, up by 6.90 points or 4.66% from its previous closing of Rs. 148.10 on the BSE.
The scrip opened at Rs. 155.00 and has touched a high and low of Rs. 155.00 and Rs. 155.00 respectively. So far 22 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 242.40 on 09-Oct-2018 and a 52 week low of Rs. 99.75 on 11-Jun-2018.
Last one week high and low of the scrip stood at Rs. 158.60 and Rs. 137.70 respectively. The current market cap of the company is Rs. 249.85 crore.
The promoters holding in the company stood at 33.52% and Non-Institutions held 66.48 %.
Zim Laboratories has received an approval for incorporation of Subsidiary in Latvia. The Board of Directors in its meeting held on February 22, 2019, approved the same.
The Board has also given approval for establishment of Representative Office in Vietnam.
Zim Laboratories has established itself as one of the preferred healthcare solution providers in the field of New Drug Delivery Systems (NDDS).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |